Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arterial Stiffness, Cognition and Equol

NCT05741060 is registered in ClinicalTrials.gov with Akira Sekikawa as lead sponsor.

NCT NCT05741060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05741060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arterial Stiffness, Cognition and Equol
Lead sponsor
Akira Sekikawa
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 29, 2023
Completion date
January 30, 2027
Enrollment
369 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arterial stiffness, cognitive decline, white matter lesions